ARS Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2025 | 10.86 M | $189.52 M | 0.00% | 11.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2025 | 9.72 M | $169.69 M | -7.51% | 9.89% |
| ORBIMED ADVISORS LLC | 08/14/2025 | 8.29 M | $144.63 M | 0.00% | 8.43% |
| BLACKROCK, INC. | 08/12/2025 | 4.42 M | $77.19 M | 2.90% | 4.50% |
| SR ONE CAPITAL MANAGEMENT, LP | 08/14/2025 | 4.01 M | $70.03 M | 0.00% | 4.08% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2025 | 3.83 M | $66.76 M | -2.47% | 3.89% |
| VANGUARD GROUP INC | 08/11/2025 | 3.26 M | $56.93 M | -6.47% | 3.32% |
| CITADEL ADVISORS LLC | 08/14/2025 | 2.24 M | $39.13 M | 179.82% | 2.28% |
| STATE STREET CORP | 08/14/2025 | 2.19 M | $38.29 M | 8.04% | 2.23% |
| FRANKLIN RESOURCES INC | 08/12/2025 | 1.83 M | $31.91 M | -1.55% | 1.86% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2025 | 1.73 M | $30.15 M | 100.00% | 1.76% |
| SOUTHPOINT CAPITAL ADVISORS LP | 08/14/2025 | 1.71 M | $29.82 M | 100.00% | 1.74% |
| FMR LLC | 08/14/2025 | 1.57 M | $27.34 M | 58.15% | 1.59% |
| ABRDN PLC | 07/24/2025 | 1.50 M | $26.22 M | 49.86% | 1.53% |
| GOLDMAN SACHS GROUP INC | 08/14/2025 | 1.46 M | $25.55 M | 103.96% | 1.49% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2025 | 1.43 M | $25.01 M | 987.59% | 1.46% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2025 | 1.35 M | $23.56 M | 116.00% | 1.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.34 M | $23.43 M | 6.50% | 1.36% |
| BIOIMPACT CAPITAL LLC | 08/14/2025 | 1.30 M | $22.74 M | -0.74% | 1.33% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/14/2025 | 1.29 M | $22.60 M | 25.83% | 1.32% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2025 | 1.10 M | $19.20 M | -31.25% | 1.12% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 878.16 K | $15.32 M | 8.81% | 0.89% |
| UBS GROUP AG | 08/14/2025 | 866.94 K | $15.13 M | 46.64% | 0.88% |
| NEXTECH INVEST, LTD. | 08/14/2025 | 741.73 K | $12.94 B | -20.82% | 0.75% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 673.37 K | $11.75 M | -4.73% | 0.68% |
| NEXT CENTURY GROWTH INVESTORS LLC | 08/14/2025 | 622.82 K | $10.87 M | 100.00% | 0.63% |
| BARCLAYS PLC | 08/14/2025 | 622.24 K | $10.86 M | 371.27% | 0.63% |
| JANNEY MONTGOMERY SCOTT LLC | 07/17/2025 | 591.43 K | $10.32 M | 31.82% | 0.60% |
| NORTHERN TRUST CORP | 08/13/2025 | 485.01 K | $8.46 M | -0.42% | 0.49% |
| ARDSLEY ADVISORY PARTNERS LP | 08/14/2025 | 475.00 K | $8.29 M | 46.15% | 0.48% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2025 | 464.03 K | $8.10 M | 100.00% | 0.47% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 08/01/2025 | 456.98 K | $7.97 M | -8.94% | 0.46% |
| FIRST TURN MANAGEMENT, LLC | 08/14/2025 | 455.95 K | $7.96 M | -31.85% | 0.46% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 442.20 K | $7.72 M | 6.13% | 0.45% |
| LISANTI CAPITAL GROWTH, LLC | 08/07/2025 | 420.08 K | $7.33 M | 116.72% | 0.43% |
| MORGAN STANLEY | 08/15/2025 | 383.62 K | $6.69 M | -13.31% | 0.39% |
| WEXFORD CAPITAL LP | 08/14/2025 | 382.56 K | $6.68 M | -6.36% | 0.39% |
| AMERIPRISE FINANCIAL INC | 08/14/2025 | 345.06 K | $6.02 M | 231.43% | 0.35% |
| FIRST TRUST ADVISORS LP | 08/13/2025 | 340.12 K | $5.94 M | 100.00% | 0.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2025 | 329.07 K | $5.74 M | 92.30% | 0.33% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2025 | 325.65 K | $5.68 M | 16.37% | 0.33% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 325.35 K | $5.68 M | -26.84% | 0.33% |
| NEUBERGER BERMAN GROUP LLC | 08/25/2025 | 324.88 K | $5.67 M | 2.37% | 0.33% |
| K2 PRINCIPAL FUND, L.P. | 08/14/2025 | 317.13 K | $5.53 M | -34.66% | 0.32% |
| WOODLINE PARTNERS LP | 08/14/2025 | 300.42 K | $5.24 M | -49.96% | 0.31% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 07/25/2025 | 294.11 K | $5.13 M | -20.20% | 0.30% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2025 | 290.09 K | $5.06 M | 0.00% | 0.29% |
| LEVIN CAPITAL STRATEGIES, L.P. | 08/05/2025 | 289.15 K | $5.05 M | -75.17% | 0.29% |
| DIADEMA PARTNERS LP | 08/14/2025 | 280.70 K | $4.90 M | 100.00% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 256.97 K | $4.48 M | 25.84% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 220 institutional investors and hedge funds held shares of ARS Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VOYA INVESTMENT MANAGEMENT LLC: 114,853
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV: 83,225
AssuredPartners Investment Advisors, LLC: 57,785
Permanent Capital Management, LP: 53,341
SIGNATUREFD, LLC: 2,812
CWM, LLC: 2,547
85.93% of ARS Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 90.05 M shares in the last 24 months. This purchase volume represents approximately $891.52 M in transactions.